stoxline Quote Chart Rank Option Currency Glossary
Medigus Ltd. (MDGS)
2.36  0.22 (10.28%)    04-17 16:00
Open: 2.21
High: 2.5799
Volume: 25,629
Pre. Close: 2.14
Low: 2.17
Market Cap: 4(M)
Technical analysis
2024-05-28 3:53:38 PM
Short term     
Mid term     
Targets 6-month :  2.79 1-year :  3.44
Resists First :  2.39 Second :  2.95
Pivot price 2
Supports First :  1.5 Second :  1.24
MAs MA(5) :  1.62 MA(20) :  2.14
MA(100) :  2.88 MA(250) :  3.64
MACD MACD :  -0.3 Signal :  -0.3
%K %D K(14,3) :  7.4 D(3) :  7.5
RSI RSI(14): 28.3
52-week High :  7.17 Low :  1.5
Price, MAs and Bollinger Bands

Price has closed below its short-term moving average. Short-term moving average is currently below mid-term; and below long-term moving average. From the relationship between price and moving averages: This stock is BEARISH in short-term; and BEARISH in mid-long term.
[ MDGS ] has closed above bottom band by 17.2%. Bollinger Bands are 154.9% wider than normal. The large width of the bands suggest high volatility as compared to its normal range. The bands have been in this wide range for 7 days. This is a sign that the current trend might continue.

Stock Price Prediction
If tomorrow: Open lower Open higher
High: 1.8 - 1.81 1.81 - 1.82
Low: 1.49 - 1.5 1.5 - 1.51
Close: 1.7 - 1.71 1.71 - 1.72
Company Description

Medigus Ltd., a technology-based company, provides medical-related devices and products in the United States, Europe, China, Israel, and internationally. It offers Medigus Ultrasonic Surgical Endostapler, an endoscopy system, which is used for the treatment of gastroesophageal reflux disease. The company also develops biological gels to protect patients against biological threats and reduce the intrusion of allergens and viruses through the upper airways and eye cavities. In addition, it develops, markets, and distributes software for internet users; and operates online stores for the sale of various consumer products on the Amazon online marketplace, as well as an online event management and ticketing platform. Further, the company develops, produces, and markets miniaturized imaging equipment, visualization solutions, and resistant cameras; electric vehicles; and wireless vehicle battery charging technologies. Medigus Ltd. was incorporated in 1999 and is headquartered in Tel Aviv-Yafo, Israel.

Headline News

Thu, 18 Apr 2024
Medigus Ltd. will Change its Ticker to XYLO from MDGS -

Mon, 15 Apr 2024
Xylo Technologies Ltd. Confronts Shareholder Lawsuit - - TipRanks

Tue, 09 Apr 2024
Medigus Ltd. Rebrands as Xylo Technologies - - TipRanks

Tue, 09 Apr 2024
Medigus to rebrand as Xylo Technologies with new Nasdaq ticker -

Tue, 09 Apr 2024
Medigus Announces Corporate Rebranding Changes Name to Xylo Technologies Ltd. to Reflect Core Values of its ... - GlobeNewswire

Mon, 01 Apr 2024
Medigus Reaps Success with First Installation of a Wireless Charging System for Automatic Car Parks - GlobeNewswire

Financial Analysis
Price to Book Value:
P/BV, a ratio used to compare book value to its current market price, to gauge whether a stock is valued properly.
Price to Earnings:
PE, the ratio for valuing a company that measures its current share price relative to its earnings per share (EPS).
Discounted cash flow:
DCF, a valuation method used to estimate the value of an investment based on its expected future cash flows.
Return on Assets:
ROA, indicates how profitable a company is in relation to its total assets, how efficiently uses assets to generate a profit.
Return on Equity:
ROE, a measure of financial performance calculated by dividing net income by equity. a gauge of profitability and efficiency.
Debt to Equity:
evaluate financial leverage, reflects the ability of equity to cover outstanding debts in the event of a business downturn.
Stock Basics & Statistics
Medical - Devices
Shares Out 2 (M)
Shares Float 26 (M)
Held by Insiders 0 (%)
Held by Institutions 0.2 (%)
Shares Short 4 (K)
Shares Short P.Month 5 (K)
Stock Financials
EPS -8.7
EPS Est Next Qtrly 0
EPS Est This Year 0
EPS Est Next Year 0
Book Value (p.s.) 18.67
Profit Margin -13.1 %
Operating Margin -8.6 %
Return on Assets (ttm) -6.7 %
Return on Equity (ttm) -30.8 %
Qtrly Rev. Growth 52.7 %
Gross Profit (p.s.) 0
Sales Per Share 58.34
EBITDA (p.s.) -3.27
Qtrly Earnings Growth 0 %
Operating Cash Flow -6 (M)
Levered Free Cash Flow -12 (M)
Stock Valuations
PE Ratio -0.18
PEG Ratio 0
Price to Book value 0.08
Price to Sales 0.02
Price to Cash Flow -0.46
Stock Dividends
Dividend 0
Forward Dividend 0
Dividend Yield 0%
Dividend Pay Date Invalid DateTime.
Ex-Dividend Date Invalid DateTime.

StockChart iOS

StoxlineLite iOS

StoxlineLite iOS

OptionCalc iOS

StockChart Android

StoxlineLite Android

StoxlinePro Android

OptionCalc Android